The aim of our study was to evaluate the expression of PKM2 and LDHA in pancreatic pre-neoplastic lesions (cysts and pancreatic intraepithelial neoplasia, PanIN) and cancers and to correlate it with patient outcome. Here, LDHA is linked to cancer.